SEARCH

History

History of Tuberculosis Vaccines

400 B.C. The Greek physician Hippocrates first describes the clinical symptoms of TB, then called phthisis
1546 Fracastorius describes Modern Theory of Contagion; believes phthisis is caused by invisible germs in the lungs.
1629 Consumption is the leading cause of death in London
1679 Franciscus Delaboe Sylvius discovers the lung nodules characteristic of TB infection (then called consumption), which he terms "tubercles".
1722 Benjamin Marten first suggests a version of the "germ theory" of TB, and speculates that it may be communicable from one individual to another
1818 Rene Laennec invents the stethoscope, thereby greatly facilitating the diagnosis of TB
1827 Reichenbach introduced Creosote as a remedy whose usage became widespread.
1839 J.L Schonlein first uses the term "tuberculosis" for the name of the disease
1859 Brehmer establishes first successful sanatorium for tuberculosis in Silesia, Germany
1862 Louis Pasteur fully formulates the germ theory of tuberculosis
1864 Boston prohibits use of milk from diseased cows
1865 Villemin proved tuberculosis caused by a small transmissible agent that produced disease in rabbits
1882 Robert Koch discovers tubercle bacilli and proves it is infectious agent that causes tuberculosis. The same year, Louis Pasteur demonstrates the use of attenuated bacilli as a vaccine
1890 Koch announces his creation of "tuberculin". While providing little protective or curative effects, tuberculin was, and still is, an effective diagnostic tool
1895 Roentgen discovered the X-ray which became a basic tool for detection of tuberculosis
1902 The Cross of Lorraine (double barred cross) is adopted as the international emblem in the fight against tuberculosis
1907 Intradermal tuberculin diagnostic skin test introduced by Charles Mantoux
1908 Calmette and Guerin begin development of TB vaccine at Pasteur lab in Lille, France
1920 The International Union Against Tuberculosis (IUAT) is founded
1921 The resulting Bacille Calmette-Guerin vaccine, termed BCG, is first used in humans by Weil-Halle and protected a newborn infant in Paris
1927 Thirty-three medical journals are devoted exclusively to tuberculosis
1928 BCG accepted by League of Nations Health Committee
1930 Several hundred babies accidentally given virulent tuberculosis instead of BCG vaccine — the "Lubeck disaster"
1945-1948 International TB Campaign administers BCG vaccine to over 8 million children in Europe, in fight against post-WWII TB epidemic
1947 Streptomycin, discovered by Waksman and Schatz in 1944, shown to be first potent drug against tuberculosis, soon followed by para-amino salicylic acid (PAS).
1952 Roche introduces isoniazid antibiotic shown to be highly effective against TB
1960 Dr John Crofton, a TB expert, proposed that a combination of drugs — Streptomycin, PAS and Isoniazid — made TB completely curable and declared "all out war" to conquer the disease.
1970 First outbreak of drug resistant TB in USA.
1993 The World Health Organization declares TB a global emergency, estimating that one third of the world's population (2 billion people) is latently infected with TB and 7-8 million cases of active TB occur each year. Directly Observed Therapy Short Course (DOTS) strategy recommended by WHO and introduced to endemic countries.
1995 The first recorded outbreak of MDR-TB at a London hospital HIV Unit.
2002 First molecular biology TB vaccine candidate using modified vaccinia Ankara (MVA85A) designed by A. Hill and H. McShane at Oxford University enters clinical testing.
2005 First Aeras recombinant BCG vaccine, designed by M. Horwitz at UCLA, enters human trials.
2006 The Stop TB Partnership launched its Action Plan to Stop Tuberculosis 2006-2015. In the same year, the Aeras Global TB Vaccine Foundation, after receiving an $82.9 million grant from the Bill and Melinda Gates Foundation, expands laboratory dedicated to improving the TB vaccine.
2007 The Bill & Melinda Gates Foundation donates additional $280 million to further research on TB treatment, vaccines, and diagnostic tools.



   site by Darby Communications